First Time Loading...

Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 4.47 USD 1.36%
Updated: May 20, 2024

Design Therapeutics Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Design Therapeutics Inc
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Design Therapeutics Inc
NASDAQ:DSGN
Depreciation & Amortization
$537k
CAGR 3-Years
277%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.6B
CAGR 3-Years
2%
CAGR 5-Years
37%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
$2.7B
CAGR 3-Years
20%
CAGR 5-Years
14%
CAGR 10-Years
18%
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$4.6B
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$196m
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$435.6m
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Design Therapeutics Inc's Depreciation & Amortization?
Depreciation & Amortization
537k USD

Based on the financial report for Dec 31, 2023, Design Therapeutics Inc's Depreciation & Amortization amounts to 537k USD.

What is Design Therapeutics Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
277%

Over the last year, the Depreciation & Amortization growth was 31%. The average annual Depreciation & Amortization growth rates for Design Therapeutics Inc have been 277% over the past three years .